Financial Markets

Clinical medicine often treats cost as a secondary concern, the awkward subject raised after the care plan is already written....

Healthcare consumerism is often described as a patient-driven phenomenon, the natural outcome of digital tools and rising expectations. That description...

A single infusion of CAR-T cells can redefine a cancer patient’s prognosis while simultaneously igniting scrutiny over a $475,000 price...

Hospitals are being bought faster than patients can heal. In 2025, the healthcare industry is in the throes of another...

In a climate of pervasive economic doubt—marked by persistent inflation, sluggish consumer spending, and wavering investor confidence—the United Kingdom’s financial...

In a historic policy shift, Medicare has begun direct negotiations on the prices of 10 widely used prescription drugs, marking...

Delays in Social Security payments can leave seniors and disabled individuals struggling to afford out-of-pocket healthcare costs. Learn how disruptions...

By denying coverage for high-risk individuals or expensive treatments, insurance companies can reduce their exposure to financial losses.

The loss of Medicaid coverage among Americans eligible for both Medicare and Medicaid was reduced during COVID emergency.

Private Medicaid health plans lost millions of members in the past year as pandemic protections that prohibited states from dropping...

In the face of a potential H5N1 bird flu pandemic, the world is woefully unprepared not only in terms of...

Drug development for infectious diseases has nearly halted, outside of COVID therapy. Antibiotics net little profit and are subject to...